The effect of anti-SARS-CoV-2 monoclonal antibody, bamlanivimab, on endogenous immune response to COVID-19 vaccination
Robert J. Benschop, Jay L. Tuttle, Lin Zhang, Josh Poorbaugh, Nicole L. Kallewaard, Peter Vaillancourt, Melissa Crisp, Thi Ngoc Vy Trinh, Joshua J. Freitas, Stephanie Beasley, Montanea Daniels, View ORCID ProfileNatalie Haustrup, Richard E. Higgs, Ajay Nirula, Myron S. Cohen, Mary Marovich
doi: https://doi.org/10.1101/2021.12.15.21267605
Robert J. Benschop
1Eli Lilly and Company, Indianapolis, IN, USA
Jay L. Tuttle
1Eli Lilly and Company, Indianapolis, IN, USA
Lin Zhang
1Eli Lilly and Company, Indianapolis, IN, USA
Josh Poorbaugh
1Eli Lilly and Company, Indianapolis, IN, USA
Nicole L. Kallewaard
1Eli Lilly and Company, Indianapolis, IN, USA
Peter Vaillancourt
1Eli Lilly and Company, Indianapolis, IN, USA
Melissa Crisp
1Eli Lilly and Company, Indianapolis, IN, USA
Thi Ngoc Vy Trinh
1Eli Lilly and Company, Indianapolis, IN, USA
Joshua J. Freitas
1Eli Lilly and Company, Indianapolis, IN, USA
Stephanie Beasley
1Eli Lilly and Company, Indianapolis, IN, USA
Montanea Daniels
1Eli Lilly and Company, Indianapolis, IN, USA
Natalie Haustrup
1Eli Lilly and Company, Indianapolis, IN, USA
Richard E. Higgs
1Eli Lilly and Company, Indianapolis, IN, USA
Ajay Nirula
1Eli Lilly and Company, Indianapolis, IN, USA
Myron S. Cohen
2Institute of Global Health and Infectious Diseases, University of North Carolina at Chapel Hill
Mary Marovich
3Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland
Article usage
Posted December 16, 2021.
The effect of anti-SARS-CoV-2 monoclonal antibody, bamlanivimab, on endogenous immune response to COVID-19 vaccination
Robert J. Benschop, Jay L. Tuttle, Lin Zhang, Josh Poorbaugh, Nicole L. Kallewaard, Peter Vaillancourt, Melissa Crisp, Thi Ngoc Vy Trinh, Joshua J. Freitas, Stephanie Beasley, Montanea Daniels, Natalie Haustrup, Richard E. Higgs, Ajay Nirula, Myron S. Cohen, Mary Marovich
medRxiv 2021.12.15.21267605; doi: https://doi.org/10.1101/2021.12.15.21267605
The effect of anti-SARS-CoV-2 monoclonal antibody, bamlanivimab, on endogenous immune response to COVID-19 vaccination
Robert J. Benschop, Jay L. Tuttle, Lin Zhang, Josh Poorbaugh, Nicole L. Kallewaard, Peter Vaillancourt, Melissa Crisp, Thi Ngoc Vy Trinh, Joshua J. Freitas, Stephanie Beasley, Montanea Daniels, Natalie Haustrup, Richard E. Higgs, Ajay Nirula, Myron S. Cohen, Mary Marovich
medRxiv 2021.12.15.21267605; doi: https://doi.org/10.1101/2021.12.15.21267605
Subject Area
Subject Areas
- Addiction Medicine (316)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2298)
- Dermatology (202)
- Emergency Medicine (371)
- Epidemiology (11623)
- Forensic Medicine (10)
- Gastroenterology (683)
- Genetic and Genomic Medicine (3629)
- Geriatric Medicine (341)
- Health Economics (622)
- Health Informatics (2332)
- Health Policy (919)
- Hematology (336)
- HIV/AIDS (758)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (394)
- Neurology (3390)
- Nursing (193)
- Nutrition (512)
- Oncology (1777)
- Ophthalmology (526)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1013)
- Primary Care Research (410)
- Public and Global Health (6021)
- Radiology and Imaging (1238)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (143)